发明名称 |
OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1A EXPRESSION |
摘要 |
Oligonucleotides directed against the hypoxia-inducible factor-1alpha (HIF-1alpha) gene are provided for modulating the expression of HIF-1alpha. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1alpha. Methods of using these compounds for modulation of HIF-1alpha expression and for the treatment of diseases associated with the hypoxia-inducible factor-1alpha are provided. Examples of diseases are cancer and pre-eclampsia. The oligonucleotides may be composed of deoxyribonucleosides, a nucleic acid analogue, or Locked Nucleic Acid (LNA) or a combination thereof.
|
申请公布号 |
US2013116309(A1) |
申请公布日期 |
2013.05.09 |
申请号 |
US201213725540 |
申请日期 |
2012.12.21 |
申请人 |
ENZON PHARMACEUTICALS, INC.;SANTARIS PHARMA A/S;SANTARIS PHARMA A/S;ENZON PHARMACEUTICALS, INC. |
发明人 |
THRUE CHARLOTTE ALBAEK;HOG ANJA MOLHART;KRISTJANSEN PAUL E.G. |
分类号 |
A61K31/7088;C12N15/09;A61K31/70;A61K38/00;A61K45/06;A61K48/00;A61P1/00;A61P3/00;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07H21/00;C07H21/04;C12N15/113 |
主分类号 |
A61K31/7088 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|